维普中文期刊产品整合服务
15篇 您的检索式:作者名="GILBERTO T"
    题名 作者 年代 出处 被引量
1Glucose Metabolism in 105 Children and Adolescents After Pancreatectomy for Congenital Hyperinsulinism显示文摘Beltrand Jacques Caquard Marylène Arnoux Jean-Baptiste Laborde Kathleen Velho Gilberto Verkarre Virginie Rahier Jacques Brunelle Francis Nihoul-Fékété Claire Saudubray Jean-Marie Robert Jean-Jacques de Lonlay Pascale 2012Diabetes Care2012,,2:1
2Anticancer, antichemotactic and antimicrobial activities of marine sponges collected off the coast of Santa Catarina, southern Brazil显示文摘Noel R Monks Clea Lerner Amélia T Henriques Fabiane M Farias Elfrides E.S Schapoval Edna S Suyenaga Adriana B da Rocha Gilberto Schwartsmann Beatriz Mothes 2002Journal of Experimental Marine Biology and Ecology2002,,1:1
3Restructuring hospital industry to control public health care expenditure:the role of input substitutability显示文摘Massimiliano P Gilberto T Davide V 2010Economic Modelling2010,27,4:1
4Maciel Extensive Experience and Validation of Polyethylene Glycol Precipitation as a Screening Method for Macroprolactinemia 显示文摘Jose Gilberto H Vieira Teresinha T Tachibana Leda H 1998Clin Chem1998,44,8:1
5Mobilization and r-ecovery of energy stores in trai′ra,Hoplias malabaricus bloch(Teleostei,Erythrinidae)during long-term starvation and after re-feeding显示文摘Flavia S R Gilberto M Eliane T O 2006Comp Physiol B2006,176,:1
6Integrated waste-to-energy conversion and waste transportation within island communities 显示文摘ZDENA Z GILBERTO T VIRIATO S 2009Energy2009,34,:1
7BRAF mutation in pa- pillary thyroid cancer and its value in tailoring treatment : a system- atic review and recta-analysis显示文摘Ralph P T Gilberto V T Justin B 2012Medicine (Baltimore)2012,91,5:1
8Comparative study of the biochemical changes and volatile compound formations during the production of novel whey-based kefir beverages and traditional milk kefir显示文摘Karina T Magalhaes Giuliano Dragone Gilberto V de Melo Pereira 2011Food Chemistry2011,126,1:1
9Comparative Study of the Biochemical Changes and Volatile Compound Forma- tions during the Production of Novel Whey-Based Kefir Beverages and Traditional Milk Kefir显示文摘KARINA T M GIULIANO D GILBERTO V 2011Food Chemistry2011,126,:1
10Perfluorooctanesulfonate and related fluorochemicals in albatrosses, elephant seals, penguins, and polar skuas from the southern ocean显示文摘Tao L Kurunthachalam K Natsuko K Monica MC Gilberto F Shin T Shinsuke T 2006Envi- ronmental Science Technology2006,40,24:1
11Networked Predictive Control of Uncertain Constrained Nonlinear Systems:Recursive Feasibility and Input-to-state Stability Analysis显示文摘Gilberto P Parisini T 0,,01:1
12Early Identification and Linkage to Care of Persons with Chronic Hepatitis B Virus Infection - Three U.S. Sites, 2012-2014显示文摘Beckett Geoff A Ramirez Gilberto Vanderhoff Aaron Nichols Kim Chute Sara M Wyles David L Schoenbachler Ben T Bedell Deborah T Cabral Rebecca Ward John W 2014Morbidity and Mortality Weekly Report2014,,18:1
13显示文摘Gilberto S Sandra T L Julien B 2010Cellulose2010,17,6:1
14Restructuring hospital industry to control public health care expenditure: tile role of input substitutability显示文摘Massimiliano P Gilberto T Davide V 2010Economic Modelling2010,27,4:1
15Chagas heart disease:An overview of diagnosis,manifestations,treatment,and care显示文摘Chagas heart disease(CHD)affects approximately 30%of patients chronically infected with the protozoa Trypanosoma cruzi.CHD is classified into four stages of increasing severity according to electrocardiographic,echocardiographic,and clinical criteria.CHD presents with a myriad of clinical manifestations,but its main complications are sudden cardiac death,heart failure,and stroke.Importantly,CHD has a higher incidence of sudden cardiac death and stroke than most other cardiopathies,and patients with CHD complicated by heart failure have a higher mortality than patients with heart failure caused by other etiologies.Among patients with CHD,approximately 90%of deaths can be attributed to complications of Chagas disease.Sudden cardiac death is the most common cause of death(55%–60%),followed by heart failure(25%–30%)and stroke(10%–15%).The high morbimortality and the unique characteristics of CHD demand an individualized approach according to the stage of the disease and associated complications the patient presents with.Therefore,the management of CHD is challenging,and in this review,we present the most updated available data to help clinicians and cardiologists in the care of these patients.We describe the clinical manifestations,diagnosis and classification criteria,risk stratification,and approach to the different clinical aspects of CHD using diagnostic tools and pharmacological and non-pharmacological treatments.Roberto M Saraiva Mauro Felippe F Mediano Fernanda SNS Mendes Gilberto Marcelo Sperandio da Silva Henrique H Veloso Luiz Henrique C Sangenis Paula Simplício da Silva Flavia Mazzoli-Rocha Andréa S Sousa Marcelo T Holanda Alejandro M Hasslocher-Moreno 2021World Journal of Cardiology2021,13,12:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费